心律管理设备的全球市场：按产品、按应用、按最终用户、按地区

全球心律管理设备市场规模预计将从2024年的175.1亿美元增加到2031年的231亿美元，2024年至2031年间复合年增长率为4%。

图：2024 年按地区分類的心律管理设备市场占有率(%)

心律管理包括快速、缓慢和不规则心率的诊断、治疗和预防。心血管疾病盛行率的上升和全球老年人口的不断增长可能会推动对心律管理设备的需求。科技的进步促进了微型植入设备的发展，并提高了患者的生活品质。然而，外科手术和设备的高成本可能会阻碍市场成长。心律管理设备市场的成长是由新兴国家产品核可的增加和扩展所推动的。

市场动态：

心律管理设备的全球市场成长是由于与心率异常相关的心血管疾病盛行率上升以及技术进步导致先进植入设备的发展所推动的。根据世界卫生组织统计，每年有超过 1700 万人死于心血管疾病，其中大部分是由心律不整引起的。老年人口的增加也是市场成长的动力，因为老化会增加心律不整的风险。然而，先进植入设备和植入外科手术的高价格可能会阻碍市场成长。市场参与企业正在透过获得新应用创新设备的核准来释放新的机会，并透过经销商合作伙伴关係和合资企业扩展到亚太地区、拉丁美洲、中东和非洲的新兴市场。

本研究的主要特点

该报告详细分析了全球心律管理设备市场，包括以2023年为基准年的预测期（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）。

它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。

基于公司亮点、产品系列、主要亮点、绩效和策略等参数的全球心律管理设备市场的主要企业概况。

主要企业包括美敦力 (Medtronic)、雅培 (Abbott)、波士顿科学 (Boston Scientific)、百多力 (Biotronik)、LivaNova 等。

本报告中的见解将帮助负责人和公司经营团队就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。

全球心律管理设备市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

透过用于分析全球心律管理设备市场的各种策略矩阵，将促进相关人员的决策。

目录

第一章 研究目的与前提

• 研究目的
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

• 市场动态
  • 促进因素
  • 抑制因素
  • 机会
• 影响分析
• 市场趋势
• 主要进展
• 监管场景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

第四章全球心律管理设备市场 - 新型冠状病毒 (COVID-19) 大流行的影响

• 整体影响
• 政府倡议
• COVID-19 对市场的影响

第五章全球心律管理设备市场：依产品（2019-2031）

• 心律调节器
• 心臟去颤器
• 心臟再同步治疗装置

第六章全球心律管理设备市场：依应用分类（2019-2031）

• 郁血性心臟衰竭
• 心律不整
• 心搏过缓
• 心搏过速
• 其他的

第七章全球心律管理设备市场：依最终用户分类（2019-2031）

• 医院
• 心臟护理中心
• 门诊手术中心
• 其他的

第八章全球心律管理设备市场：按地区（2019-2031）

• 拉丁美洲
• 欧洲
• 亚太地区
• 中东

第9章 竞争格局

• 公司简介
  • Abbott Laboratories
  • Abiomed
  • Biotronik SE &Co. KG
  • Boston Scientific Corporation
  • Koninklijke Philips NV
  • LivaNova PLC
  • Medtronic PLC
  • Schiller AG
  • Physio-Control, Inc.
  • Progetti Srl
  • Zoll Medical Corporation
  • Cardiac Science
  • Defibtech, LLC
  • Asahi Kasei Corporation
  • MicroPort Scientific Corporation
  • St. Jude Medical, Inc.
  • CU Medical Systems Inc.

第10章分析师建议

• Wheel of Fortune
• 分析师观点
• Coherent Opportunity Map（COM）

第十一章调查方法

• 参考
• 调查方法

Global cardiac rhythm management devices market is estimated to be valued at USD 17.51 Bn in 2024 and is expected to reach USD 23.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 4% from 2024 to 2031.

Figure. Cardiac Rhythm Management Devices Market Share (%), By Region 2024

Cardiac rhythm management includes diagnosis, treatment, and prevention of fast, slow, or irregular heartbeats. Rising prevalence of cardiovascular diseases and growing geriatric population worldwide can boost demand for cardiac rhythm management devices. Technological advancements have enabled development of miniaturized implantable devices, offering improved quality of life to patients. However, high costs of surgical procedures and devices can hamper the market growth. Cardiac rhythm management devices market growth is driven by rising product approvals and expansions in emerging nations.

Market Dynamics:

Global cardiac rhythm management devices market growth is driven by rising prevalence of cardiovascular disorders associated with heart rhythm abnormalities and technological advancements leading to development of sophisticated implantable devices. According to WHO, cardiovascular diseases account for over 17 million deaths annually, a majority of which are caused due to irregular heartbeats. Growing geriatric population also drives the market growth, as aging increases risk of developing arrhythmias. However, high costs of sophisticated implantable devices and surgical procedures to implant them can hamper the market growth. Market players can witness new opportunities by gaining approvals for innovative devices in newer applications and expanding to emerging countries in Asia Pacific, Latin America, and Middle East & Africa through distributor partnerships and JVs.

Key Features of the Study:

This report provides in-depth analysis of the global cardiac rhythm management devices market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global cardiac rhythm management devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Medtronic, Abbott, Boston Scientific, Biotronik, and LivaNova

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global cardiac rhythm management devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiac rhythm management devices market

Detailed Segmentation-

• By Product
  • Pacemakers
  • Defibrillators
  • Cardiac Resynchronization Therapy Devices
• By Application
  • Congestive heart failure
  • Arrhythmias
  • Bradycardia
  • Tachycardia Others
• By End User
  • Hospitals
  • Cardiac care centers
  • Ambulatory surgical centers
  • Others
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Abbott Laboratories
  • Abiomed
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Koninklijke Philips NV
  • LivaNova PLC
  • Medtronic PLC
  • Schiller AG
  • Physio-Control, Inc.
  • ProgettiSrl
  • Zoll Medical Corporation
  • Cardiac Science
  • Defibtech, LLC
  • Asahi Kasei Corporation
  • MicroPort Scientific Corporation
  • Jude Medical, Inc.
  • CU Medical Systems Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Cardiac Rhythm Management Devices Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Cardiac Rhythm Management Devices Market, By Product, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Pacemakers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Defibrillators
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Cardiac Resynchronization Therapy Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Cardiac Rhythm Management Devices Market, By Application, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Congestive heart failure
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Arrhythmias
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Bradycardia
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Tachycardia
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Cardiac Rhythm Management Devices Market, By End User, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Cardiac care centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Ambulatory Surgical Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Cardiac Rhythm Management Devices Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Abbott Laboratories
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Abiomed
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Biotronik SE & Co. KG
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Koninklijke Philips NV
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • LivaNova PLC
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Medtronic PLC
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Schiller AG
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Physio-Control, Inc.
  • Progetti Srl
  • Zoll Medical Corporation
  • Cardiac Science
  • Defibtech, LLC
  • Asahi Kasei Corporation
  • MicroPort Scientific Corporation
  • St. Jude Medical, Inc.
  • CU Medical Systems Inc.

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. Research Methodology

• References
• Research Methodology
• About us and Sales Contact